These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10573477)

  • 41. Bilateral facial weakness.
    Sivaswamy L; Neil E
    J Pediatr; 2012 Sep; 161(3):560-1. PubMed ID: 22608903
    [No Abstract]   [Full Text] [Related]  

  • 42. [Immunoglobulins in the therapy of the Guillain-Barré syndrome in childhood].
    Koelfen W; Rohr H
    Dtsch Med Wochenschr; 1994 Oct; 119(42):1449-50. PubMed ID: 7956764
    [No Abstract]   [Full Text] [Related]  

  • 43. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome.
    Gürses N; Uysal S; Cetinkaya F; Işlek I; Kalayci AG
    Scand J Infect Dis; 1995; 27(3):241-3. PubMed ID: 8539548
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Guillain-Barré syndrome in a 93-year-old woman: rapid improvement of neurologic function following intravenous immunoglobulin.
    Uldry PA; Bogousslavsky J; Regli F
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(4):301-5. PubMed ID: 1719624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efalizumab-associated Guillain-Barre syndrome.
    Victor F; Menon K; Latkowski JA; Fernandez-Obregon A; Strober BE
    Arch Dermatol; 2008 Oct; 144(10):1396-7. PubMed ID: 18936412
    [No Abstract]   [Full Text] [Related]  

  • 46. A toddler with stridor and leg weakness.
    Godiwala N; Steele RW
    Clin Pediatr (Phila); 2010 Aug; 49(8):809-11. PubMed ID: 20651258
    [No Abstract]   [Full Text] [Related]  

  • 47. Intravenous immunoglobulin as therapy for pediatric Guillain-Barré syndrome.
    Abd-Allah SA; Jansen PW; Ashwal S; Perkin RM
    J Child Neurol; 1997 Sep; 12(6):376-80. PubMed ID: 9309521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adverse effect of polyvalent immunoglobulin in the treatment of Guillain-Barre syndrome.
    Chamouni P; Tamion F; Gueit I; Girault C; Lenain P; Varin R; Czernichow P
    Transfus Apher Sci; 2003 Apr; 28(2):117-24. PubMed ID: 12679114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recurrent Guillain-Barre syndrome as a complication of immune reconstitution in HIV.
    Makela P; Howe L; Glover S; Ferguson I; Pinto A; Gompels M
    J Infect; 2002 Jan; 44(1):47-9. PubMed ID: 11972420
    [No Abstract]   [Full Text] [Related]  

  • 50. When the Guillain-Barre patient fails to respond to treatment.
    Winer JB
    Pract Neurol; 2009 Aug; 9(4):227-30. PubMed ID: 19608773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Guillain-Barré syndrome at two hospitals in Trinidad, West Indies: a review of 26 patients.
    Esack A; Teelucksingh S
    West Indian Med J; 2010 Oct; 59(5):514-7. PubMed ID: 21473398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Guillain-Barré syndrome in childhood].
    Kollár K; Liptai Z; Rosdy B; Móser J
    Ideggyogy Sz; 2009 Nov; 62(11-12):399-404. PubMed ID: 20025130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Possible applications for immunoglobulin G].
    Krankenpfl J; 2005; 43(1-3):52-3. PubMed ID: 15912842
    [No Abstract]   [Full Text] [Related]  

  • 54. Guillain-Barré syndrome in a collegiate football player.
    Ashton C; Hendrickson CD
    Clin J Sport Med; 2004 Jan; 14(1):48-9. PubMed ID: 14712167
    [No Abstract]   [Full Text] [Related]  

  • 55. Side effects of combined therapy of methylprednisolone and intravenous immunoglobulin in Guillain-Barré syndrome.
    Odaka M; Tatsumoto M; Hoshiyama E; Hirata K; Yuki N
    Eur Neurol; 2005; 53(4):194-6. PubMed ID: 15970631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of immunoglobulin in severe childhood Guillain-Barré syndrome.
    Ortiz-Corredor F; Peña-Preciado M
    Acta Neurol Scand; 2007 Apr; 115(4):289-93. PubMed ID: 17376129
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical variants of Guillain-Barre syndrome: some aspects of differential diagnosis.
    Dididze MN
    Georgian Med News; 2009 Jan; (166):48-51. PubMed ID: 19202218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid recovery of a child with Guillain-Barré syndrome using intravenous immunoglobulins.
    Shah M; Weinberger M
    J La State Med Soc; 1998 Nov; 150(11):533-7. PubMed ID: 9861805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacoeconomics of therapy for Guillain-Barré syndrome: plasma exchange and intravenous immunoglobulin.
    Tsai CP; Wang KC; Liu CY; Sheng WY; Lee TC
    J Clin Neurosci; 2007 Jul; 14(7):625-9. PubMed ID: 17532498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Venous and arterial thrombosis following administration of intravenous immunoglobulins: reply to Feuillet and colleagues.
    Ben-Ami R; Paran D; Herishanu Y; Elkayam O; Shopin L
    Blood Coagul Fibrinolysis; 2005 Nov; 16(8):619. PubMed ID: 16269938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.